Hm Payson & CO Abbott Laboratories Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Hm Payson & CO holds 400,007 shares of ABT stock, worth $45.7 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

400,007

Previous 406,724 1.65%

Holding current value

$45.7 Million

Previous $42.3 Million 7.91%

% of portfolio

0.78%

Previous 0.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $672,170 - $793,479	-6,717 Reduced 1.65%	400,007 $45.6 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $1.09 Million - $1.22 Million	-10,833 Reduced 2.59%	406,724 $42.3 Million
Q1 2024 Jun 20, 2024	BUY	$109.52 - $120.96 $290,994 - $321,390	2,657 Added 0.64%	417,557 $47.5 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $588,850 - $720,801	-6,529 Reduced 1.55%	414,900 $45.7 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $225,832 - $270,961	-2,364 Reduced 0.56%	421,429 $40.8 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $1.56 Million - $1.74 Million	-15,506 Reduced 3.53%	423,793 $46.2 Million
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $46,008 - $54,154	-475 Reduced 0.11%	439,299 $44.5 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $618,080 - $725,103	-6,502 Reduced 1.46%	439,774 $48.3 Million
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $650,614 - $753,289	-6,724 Reduced 1.48%	446,276 $43.2 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $1.91 Million - $2.31 Million	-18,712 Reduced 3.97%	453,000 $49.2 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $903,950 - $1.1 Million	-7,928 Reduced 1.65%	471,712 $55.8 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $478,294 - $585,644	-4,140 Reduced 0.86%	479,640 $67.5 Million
Q3 2021 Nov 30, 2021	SELL	$116.66 - $129.06 $262,135 - $289,997	-2,247 Reduced 0.46%	483,780 $57.1 Million
Q2 2021 Aug 17, 2021	SELL	$105.79 - $124.53 $290,076 - $341,461	-2,742 Reduced 0.56%	486,027 $56.3 Million
Q1 2021 Jun 15, 2021	SELL	$108.84 - $128.23 $406,190 - $478,554	-3,732 Reduced 0.76%	488,769 $58.6 Million
Q4 2020 Mar 10, 2021	SELL	$105.0 - $114.42 $1.43 Million - $1.56 Million	-13,592 Reduced 2.69%	492,501 $53.9 Million
Q3 2020 Dec 21, 2020	SELL	$91.64 - $111.29 $258,149 - $313,503	-2,817 Reduced 0.55%	506,093 $55.1 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $249,847 - $319,774	-3,263 Reduced 0.64%	508,910 $46.5 Million
Q1 2020 Jul 01, 2020	SELL	$62.82 - $91.86 $683,041 - $998,793	-10,873 Reduced 2.08%	512,173 $40.4 Million
Q4 2019 Feb 18, 2020	SELL	$78.51 - $87.4 $358,869 - $399,505	-4,571 Reduced 0.87%	523,046 $45.4 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $461,659 - $500,582	5,641 Added 1.08%	527,617 $44.1 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $952,978 - $1.11 Million	-13,076 Reduced 2.44%	521,976 $43.9 Million
Q1 2019 Jul 31, 2019	BUY	$66.22 - $80.06 $35.2 Million - $42.5 Million	530,994 Added 13085.12%	535,052 $42.8 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $30.9 Million - $35 Million	-471,304 Reduced 99.15%	4,058 $294,000
Q3 2018 Nov 30, 2018	SELL	$60.81 - $73.36 $1.86 Million - $2.25 Million	-30,667 Reduced 6.06%	475,362 $34.9 Million
Q2 2018 Aug 27, 2018	SELL	$57.57 - $63.54 $6.62 Million - $7.31 Million	-115,061 Reduced 18.53%	506,029 $30.9 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $2.67 Million - $3.02 Million	-47,482 Reduced 7.1%	621,090 $37.2 Million
Q4 2017 Feb 16, 2018	SELL	$53.68 - $57.47 $594,989 - $636,997	-11,084 Reduced 1.63%	668,572 $38.2 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $32.7 Million - $36.5 Million	679,656	679,656 $36.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account